Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Go back to Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
(NASDAQ: VRCA) Delayed: 6.62 --0 (-0%)
Previous Close $6.62    52 Week High
Open $6.62    52 Week Low
Day High $6.62    P/E N/A 
Day Low $6.62    EPS
Volume 219